CSI Market
Sign In | Register

Exousia Bio (LMMY) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access LMMY Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Exousia Bio.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Feb 28 2026)
(Nov 30 2025) (Aug 31 2025) (May 31 2025) (Feb 28 2025)
Assets
Cash & Short-term Investments0.00
Total Current Assets0.00
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent22.05
Total Assets22.05
Liabilities
Accounts Payable0.21
Other Liabilities, Current0.05
Total Current Liabilities0.26
Total Long-term Debt0.00
Total Liabilities0.26
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock22.07
Retained Earnings / Accumulated Deficit-0.29
Common Stockholder's Equity21.79
Total Stockholder's Equity21.79
Liabilities & Stockholder's Equity22.05
4 historic quarters locked

Sign in to unlock the full Exousia Bio balance sheet history.

Sign In Create Free Account

About Exousia Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001683168-26-004868

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.